Starton Therapeutics, Inc. (“Starton” or “the Company”), a clinical-stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology,...
Healthwell Acquisition Corp. I (NASDAQ:HWELU) (“Healthwell” or the “Company”) announced that, commencing September 23, 2021, holders of the 25,000,000 units sold in the Company’s initial public...
Healthwell Acquisition Corp. I (NASDAQ: HWELU ) (“Healthwell” or the “Company”) announced the closing of its initial public offering of 25,000,000 units at a price of $10.00 per unit. The Company...
Healthwell Acquisition Corp. I (NASDAQ: HWELU ) (“Healthwell” or the “Company”) announced the pricing today of its initial public offering (“IPO”) of 25,000,000 units at a price to the public...